3rd Quarter - Report

VERTEX PHARMACEUTICALS INCORPORATED for VERTEX PHARMACEUTICALS INCORPORATED

Firm
Client
Income
—
Expenses
$1,000,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Federal policies impacting pharmaceutical development, approval, and reimbursement; Copay accumulators and maximizers, HELP Copays Act (H.R. 830/S. 1375); Alternative Funding Programs; Unmet medical need in acute pain; Barriers to patient access of non-opioid pain medicines; Genetic kidney disease, including APOL-1; Ex-US access to innovative medicines; Cystic Fibrosis; Sickle cell disease.

LobbyistCovered position, as disclosed
HANNAH BETH CORNWELL —
ERIN MENDELSOHN —
KRISTIN RICHTER —
MATTHEW O SCHUMAKER —
SWARNA VALLURUPALLI —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 830 (118th), S. 1375 (118th)

Medicare/Medicaid MMM

Unmet medical need in acute pain; H.R.7421/S.3832 - The Alternatives to PAIN Act; Implementation of Public Law No: 117-328 sec. 4135 NO PAIN Act; Medically necessary fertility treatments for patients undergoing fully myeloablative conditioning.

LobbyistCovered position, as disclosed
HANNAH BETH CORNWELL —
ERIN MENDELSOHN —
KRISTIN RICHTER —
MATTHEW O SCHUMAKER —
SWARNA VALLURUPALLI —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 7421 (118th), S. 3832 (118th)

Taxation/Internal Revenue Code TAX

Corporate tax reform.

LobbyistCovered position, as disclosed
SWARNA VALLURUPALLI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Access to non-opioids in DoD/Tricare (H.R.8774/S.4921 - Department of Defense Appropriations Act, 2025); Access to non-opioids in VHA and general support for clinical trial operations at VHA to address high prevalence diseases and conditions (H.R.8580/S.4677 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2025); Access to non-opioids for Medicare beneficiaries and education about risk of kidney disease amongst minority populations (H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025).

LobbyistCovered position, as disclosed
HANNAH BETH CORNWELL —
ERIN MENDELSOHN —
KRISTIN RICHTER —
MATTHEW O SCHUMAKER —
SWARNA VALLURUPALLI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 8774 (118th), S. 4921 (118th), S. 4677 (118th), H.R. 8580 (118th), S. 4942 (118th), H.R. 9029 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.